Acadia Healthcare (NASDAQ:ACHC) Reaches New 52-Week Low Following Analyst Downgrade

Acadia Healthcare Company, Inc. (NASDAQ:ACHC) hit a new 52-week low during mid-day trading on Friday after Bank of America lowered their price target on the stock from $50.00 to $44.50. Bank of America currently has a buy rating on the stock. Acadia Healthcare traded as low as $31.64 and last traded at $31.96, with a volume of 911368 shares changing hands. The stock had previously closed at $40.26.

Other research analysts also recently issued reports about the company. KeyCorp raised Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 target price on the stock in a report on Tuesday, January 7th. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $45.00 to $75.00 in a research note on Thursday, December 12th. Cantor Fitzgerald reissued a “neutral” rating and set a $52.00 target price on shares of Acadia Healthcare in a research report on Tuesday, December 10th. Barclays downgraded shares of Acadia Healthcare from an “overweight” rating to an “equal weight” rating and dropped their price target for the stock from $43.00 to $35.00 in a research report on Friday. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $64.00 price objective on shares of Acadia Healthcare in a research report on Friday, January 10th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $64.28.

Hedge Funds Weigh In On Acadia Healthcare

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Lindbrook Capital LLC raised its stake in Acadia Healthcare by 1,342.0% during the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock worth $29,000 after buying an additional 671 shares during the period. Blue Trust Inc. raised its position in shares of Acadia Healthcare by 69.4% during the fourth quarter. Blue Trust Inc. now owns 842 shares of the company’s stock worth $33,000 after purchasing an additional 345 shares during the period. Nisa Investment Advisors LLC lifted its holdings in shares of Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock worth $41,000 after purchasing an additional 301 shares in the last quarter. Signaturefd LLC grew its position in Acadia Healthcare by 460.6% in the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock valued at $48,000 after purchasing an additional 1,004 shares during the period. Finally, Fifth Third Bancorp increased its stake in Acadia Healthcare by 56.0% during the 4th quarter. Fifth Third Bancorp now owns 1,264 shares of the company’s stock valued at $50,000 after purchasing an additional 454 shares in the last quarter.

Acadia Healthcare Stock Performance

The stock has a market cap of $2.93 billion, a price-to-earnings ratio of 10.47, a P/E/G ratio of 1.46 and a beta of 1.30. The company’s fifty day simple moving average is $42.26 and its two-hundred day simple moving average is $52.22. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.